US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

317.20

+12.294.03%

Post-market: 317.870.6700+0.21%19:58 EDT

Volume:468.50K

Turnover:149.84M

Market Cap:689.75M

PE:- -

High:329.20

Open:311.70

Low:306.27

Close:304.91

52wk High:341.93

52wk Low:66.60

Shares:2.17M

Float Shares:2.17M

Volume Ratio:0.98

T/O Rate:21.55%

Dividend:1.02

Dividend Rate:0.32%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)

Trian takes boosts stakes in GE Healthcare, Wendy’s

Lupin Lupin Gets U.S. FDA Final Approval for Pitolisant Tablets

MT Newswires Live

OncoSil Flags FDA Milestone While Stressing Investor Caution

Radiopharm Theranostics to Meet With US FDA on Phase 3 Brain Metastases Diagnosis Trial

MT Newswires Live

OUE Healthcare Opens Flagship Prince Bay Hospital in Shenzhen’s Greater Bay Area

Radiopharm lines up FDA meeting to advance RAD101 brain metastasis imaging into Phase 3

160 Health Signals Profit Turnaround on Surge in Digital Healthcare Business

Nearly 1.6 Million Eggs Recalled in Southern US Due to Salmonella, FDA Flags Highest Risk

Indonesia Plans 'Flying Doctors' to Expand Healthcare Access in Remote Areas

The Bull Case For Celcuity (CELC) Could Change Following Revtopik’s FDA Approval And NCCN Category 1 Status

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)

The Bull Case For Alignment Healthcare (ALHC) Could Change Following Its Top Medicare Advantage Pick Recognition

Simply Wall St.

How Investors Are Reacting To Scholar Rock (SRRK) Dual Fill-Finish Readiness Amid Ongoing FDA Review

Simply Wall St.

This Healthcare Stock Could Jump Nearly 40%

Luigi Admits Guilt in Killing of UnitedHealthcare CEO, Could Face Life Imprisonment

Health Care Down on Growth Doubts - Health Care Roundup

Analysts’ Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)

Sector Update: Healthcare

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":317.2,"timestamp":1787342400000,"preClose":304.91,"halted":0,"volume":468504,"hourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"delay":0,"changeRate":0.04030697582893301,"floatShares":2174486,"shares":2174486,"eps":0,"marketStatus":"Not Yet Opened","change":12.29,"latestTime":"08-21 16:00:00 EDT","open":311.7,"high":329.2026,"low":306.27,"amount":149839169.98896,"amplitude":0.075211,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":304.91,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.00323,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":313.6,"preClose":304.91,"latestTime":"09:27 EDT","volume":3793,"amount":1185778.2804,"timestamp":1787318868980,"change":8.69,"changeRate":0.0285,"amplitude":0.022236},"postHourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"volumeRatio":0.9815516107169615,"impliedVol":0.9442,"impliedVolPercentile":0.6693},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2174486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9815516107169615,"shares":2174486,"dividePrice":1.0247,"high":329.2026,"amplitude":0.075211,"preClose":304.91,"low":306.27,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":317.2,"eps":0,"divideRate":0.00323,"volume":468504,"delay":0,"ttmEps":0,"open":311.7,"prevYearClose":159.39,"prevWeekClose":276.54,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":276.54,"twentyDayClose":245.6,"sixtyDayClose":186},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660048525","title":"Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660048525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660048525?lang=en_us&edition=fundamental","pubTime":"2026-08-17 17:01","pubTimestamp":1786957287,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Phathom Pharmaceuticals (PHAT) and BioMarin Pharmace...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-and-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-and-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PHAT","HCSG","IE00B19Z3B42.SGD","BK4588","XBI","BK4137","BMRN","IE00B19Z3581.USD","IE0002270589.USD","LABU","BK4139","XLV","IE00B7SZLL34.SGD","BK4581","BK4566","BK4585","LU0029874061.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660485889","title":"Trian takes boosts stakes in GE Healthcare, Wendy’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2660485889","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660485889?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:42","pubTimestamp":1786956142,"startTime":"0","endTime":"0","summary":"Nelson Peltz’s Trian Fund Management disclosed in an SEC filing its holdings as of June 30, 2026. Trian increased its stake in two holdings, includ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trian-takes-boosts-stakes-in-ge-healthcare-wendys-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trian-takes-boosts-stakes-in-ge-healthcare-wendys-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","GE","XLV","LU1280957306.USD","LU1119994496.HKD","LU1064131342.USD","LU1261432733.SGD","MISL","BK4585","LU1366192091.USD","UXI","LU0820562030.AUD","LU0689472784.USD","BK4187","LU2087625088.SGD","LU0354030511.USD","LU0354030438.USD","LU2168563687.JPY","LU0267386448.USD","EXI","LU2168564065.EUR","LU2756315664.SGD","XBI","BK4543","LU1084165304.USD","LU1551013425.SGD","LU0029874061.USD","LU0943347566.SGD","LU0640476718.USD","ITA","BK4501","LU0353189763.USD","LU0077335932.USD","BK4581","XAR","LU2264538146.SGD","BK4206","LU0868494617.USD","NATO","LU0149725797.USD","DFEN","LU0820561909.HKD","PPA","TRUI","LU2168564149.EUR","LU0820561818.USD","LU2543165471.USD","LU1093756168.USD","HCSG","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660648807","title":"Lupin Lupin Gets U.S. FDA Final Approval for Pitolisant Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2660648807","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660648807?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:14","pubTimestamp":1786954473,"startTime":"0","endTime":"0","summary":"Lupin  said the U.S. Food and Drug Administration granted final approval for its abbreviated new drug application for Pitolisant Tablets 4.45 mg and 17.8 mg, according to a filing to Indian bourses.The tablets have been approved as bioequivalent to Wakix, which is approved in the U.S. for the treatment of narcolepsy.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660023341","title":"OncoSil Flags FDA Milestone While Stressing Investor Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2660023341","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660023341?lang=en_us&edition=fundamental","pubTime":"2026-08-17 13:22","pubTimestamp":1786944148,"startTime":"0","endTime":"0","summary":"An update from OncoSil Medical Ltd ( ($AU:OSL) ) is now available. OncoSil Medical has prepared an investor webinar titled “FDA Approval: A New Cha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncosil-flags-fda-milestone-while-stressing-investor-caution?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncosil-flags-fda-milestone-while-stressing-investor-caution?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101432","title":"Radiopharm Theranostics to Meet With US FDA on Phase 3 Brain Metastases Diagnosis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101432","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660101432?lang=en_us&edition=fundamental","pubTime":"2026-08-17 11:33","pubTimestamp":1786937616,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics  will meet with the US Food and Drug Administration  on Oct. 1 to seek alignment on the design of a phase 3 trial to evaluate its RAD101 imaging agent in patients with suspected recurrence of brain metastases following radiotherapy, according to a Monday filing with the Australian bourse.The meeting will focus on the trial's design criteria, including the number of patients to be enrolled and the primary and secondary endpoints, per the filing.The FDA will also review data from a phase 2b trial of RAD 101, which showed 93% concordance between MRI and PET imaging of brain metastases in the targeted patient population, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK7067","RAD.AU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660510516","title":"OUE Healthcare Opens Flagship Prince Bay Hospital in Shenzhen’s Greater Bay Area","url":"https://stock-news.laohu8.com/highlight/detail?id=2660510516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660510516?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:42","pubTimestamp":1786927334,"startTime":"0","endTime":"0","summary":"OUE Lippo Healthcare Limited ( ($SG:5WA) ) has provided an update. OUE Healthcare’s joint venture has officially opened the Shenzhen China Merchant...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oue-healthcare-opens-flagship-prince-bay-hospital-in-shenzhens-greater-bay-area?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oue-healthcare-opens-flagship-prince-bay-hospital-in-shenzhens-greater-bay-area?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4581","BK4209","XLV","XBI","SG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660030071","title":"Radiopharm lines up FDA meeting to advance RAD101 brain metastasis imaging into Phase 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2660030071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660030071?lang=en_us&edition=fundamental","pubTime":"2026-08-17 07:37","pubTimestamp":1786923478,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics Limited ( ($AU:RAD) ) has issued an update. Radiopharm Theranostics has scheduled an End-of-Phase 2 meeting with the U.S. F...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/radiopharm-lines-up-fda-meeting-to-advance-rad101-brain-metastasis-imaging-into-phase-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/radiopharm-lines-up-fda-meeting-to-advance-rad101-brain-metastasis-imaging-into-phase-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659723581","title":"160 Health Signals Profit Turnaround on Surge in Digital Healthcare Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2659723581","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659723581?lang=en_us&edition=fundamental","pubTime":"2026-08-16 18:37","pubTimestamp":1786876674,"startTime":"0","endTime":"0","summary":"160 Health International Ltd. ( ($HK:2656) ) has issued an announcement. 160 Health International has issued a positive profit alert, indicating it...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/160-health-signals-profit-turnaround-on-surge-in-digital-healthcare-business?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/160-health-signals-profit-turnaround-on-surge-in-digital-healthcare-business?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4585","LU0128526141.USD","BK4588","BK4581","HCSG","XLV","XBI","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180307109","title":"Nearly 1.6 Million Eggs Recalled in Southern US Due to Salmonella, FDA Flags Highest Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=1180307109","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180307109?lang=en_us&edition=fundamental","pubTime":"2026-08-16 14:43","pubTimestamp":1786862586,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration (FDA) has escalated a recall involving nearly 1.6 million dozen eggs to its highest risk level (Class I) due to potential Salmonella contamination. The outbreak...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659171758","title":"Indonesia Plans 'Flying Doctors' to Expand Healthcare Access in Remote Areas","url":"https://stock-news.laohu8.com/highlight/detail?id=2659171758","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659171758?lang=en_us&edition=fundamental","pubTime":"2026-08-16 12:15","pubTimestamp":1786853702,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta- Indonesia's State Secretary Minister Prasetyo Hadi said the government’s “flying doctor” program would focus on improving access to healthcare in remote areas where medical facilities are difficult to reach, rather than providing the service in every village.Hadi was responding to a concept outlined by President Prabowo Subianto in his speech on the government’s proposed 2027 state budget and financial note at the Parliament Complex in Jakarta on Friday.“Why did the idea of flying doctors emerge? We use the term ‘flying’ because, on several occasions when we have traveled across Indonesia, we have seen that our country is very vast and access to healthcare facilities is still uneven,” he said at Merdeka Palace in Jakarta on Saturday.","market":"other","thumbnail":"https://statik.tempo.co/data/2014/10/13/id_333771/333771_620.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2014/10/13/id_333771/333771_620.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2117609/indonesia-plans-flying-doctors-to-expand-healthcare-access-in-remote-areas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2117609/indonesia-plans-flying-doctors-to-expand-healthcare-access-in-remote-areas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["VHT","BK4137","LABU","HCSG","XBI","LU0128526141.USD","BK4550","BK4585","LU0029874061.USD","XLV","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659171859","title":"The Bull Case For Celcuity (CELC) Could Change Following Revtopik’s FDA Approval And NCCN Category 1 Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2659171859","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659171859?lang=en_us&edition=fundamental","pubTime":"2026-08-16 09:21","pubTimestamp":1786843306,"startTime":"0","endTime":"0","summary":"In August 2026, Celcuity Inc. reported a wider Q2 net loss of US$78.86 million and higher basic loss per share, while securing FDA approval and a preferred Category 1 NCCN guideline recommendation for Revtopik in HR-positive, HER2-negative advanced breast cancer.\nAlongside the deeper losses, the combination of strong Phase 3 efficacy data and rapid guideline endorsement for Revtopik materially reshapes how Celcuity’s pipeline can translate into future commercial activity.\nWe’ll now examine...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/the-bull-case-for-celcuity-celc-could-change-following-revto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/the-bull-case-for-celcuity-celc-could-change-following-revto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","CELC","BK4588","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659827176","title":"Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659827176","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659827176?lang=en_us&edition=fundamental","pubTime":"2026-08-16 02:30","pubTimestamp":1786818607,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DAR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-belite-bio-inc-adr-blte-and-dare-bioscience-dare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-belite-bio-inc-adr-blte-and-dare-bioscience-dare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HCSG","AADR","BK4588","DARE","XBI","SAPH","BK4137","DIVL","LABU","ARMH","DINT","APIE","XLV","BK4584","BK4581","BLTE","BK4585","CVY","LU0029874061.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175749","title":"Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659175749?lang=en_us&edition=fundamental","pubTime":"2026-08-16 02:20","pubTimestamp":1786818008,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Mediwound (MDWD) and Capricor Therapeutics (CAPR)....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mediwound-mdwd-and-capricor-therapeutics-capr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mediwound-mdwd-and-capricor-therapeutics-capr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","HCSG","LABU","BK4588","MDWD","BK4137","BK4585","XBI","CAPR","BK4139","BK4007","LU0128526141.USD","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659017391","title":"The Bull Case For Alignment Healthcare (ALHC) Could Change Following Its Top Medicare Advantage Pick Recognition","url":"https://stock-news.laohu8.com/highlight/detail?id=2659017391","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659017391?lang=en_us&edition=fundamental","pubTime":"2026-08-15 21:27","pubTimestamp":1786800425,"startTime":"0","endTime":"0","summary":"Earlier this week, Alignment Healthcare was highlighted as a top Medicare Advantage pick thanks to strong revenue growth, improving profitability, and a solid net cash position.\nThis recognition underscores how the company’s balance between financial strength and growth ambitions is increasingly shaping investor perceptions of its business model.\nNext, we’ll examine how this focus on strong revenue growth and improving profitability could influence Alignment Healthcare’s broader investment...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/the-bull-case-for-alignment-healthcare-alhc-could-change-fol-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/the-bull-case-for-alignment-healthcare-alhc-could-change-fol-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0211331839.USD","XHS","BK4581","FXH","SG9999014021.USD","BK4539","LU0266013472.USD","XBI","XLV","LU0070302665.USD","IEHS","BK4533","BK4154","IYH","LNGR","BK4588","LABU","LU0390134368.USD","LU1983260115.SGD","LU0238689110.USD","ALHC","UNHU","SG9999014013.SGD","LU1093756325.SGD","LU1093756168.USD","SG9999014005.SGD","LU0417517546.SGD","LU0320765489.SGD","BK4585","HUM","LU0348723411.USD","BK4566","LU0170899867.USD","IHF","XLVX","LU0256863811.USD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659173150","title":"How Investors Are Reacting To Scholar Rock (SRRK) Dual Fill-Finish Readiness Amid Ongoing FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2659173150","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659173150?lang=en_us&edition=fundamental","pubTime":"2026-08-15 21:21","pubTimestamp":1786800069,"startTime":"0","endTime":"0","summary":"In early August 2026, Scholar Rock Holding Corporation reported that its second-quarter net loss was US$109.9 million, slightly lower than a year earlier, while its six-month net loss widened to US$215.41 million and loss per share stayed broadly similar.\nAt the same time, the company highlighted that its apitegromab biologics license application for spinal muscular atrophy remains under active FDA review with two independent fill-finish facilities prepared to support potential approval and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/how-investors-are-reacting-to-scholar-rock-srrk-dual-fill-fi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/how-investors-are-reacting-to-scholar-rock-srrk-dual-fill-fi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","IBRN","SRRK","ISBC","THNR","BK4585","BK4211","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659983127","title":"This Healthcare Stock Could Jump Nearly 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659983127","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659983127?lang=en_us&edition=fundamental","pubTime":"2026-08-15 09:30","pubTimestamp":1786757400,"startTime":"0","endTime":"0","summary":"Medpace has carved out a niche helping smaller biotech companies navigate the complicated regulatory process. By Todd ChankoBy the time any of us stop by our local pharmacy to pick up a medication, th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4588","LU0130103400.USD","IQV","LU1791710582.SGD","LU1989764664.SGD","LU2065171402.SGD","BK4581","LU0477156797.USD","LU1791710400.SGD","LU2065170008.USD","LU2065169927.USD","BK4530","LU2065171311.SGD","BK4121","LU0130102774.USD","LABU","FTRE","LU0648001328.SGD","NVIB","XLV","LU0528227936.USD","MEDP","HEAL","LU0128526141.USD","LU0130517989.USD","HCSG","EKG","LU0477156953.USD","LU0648000940.SGD","LU0882574055.USD","BK4585","LU0980610538.SGD","LU1201861165.SGD","LU1201861249.SGD","LU1989764748.USD","LU0198837287.USD","XBI","BK4137","LU0130518102.USD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151695113","title":"Luigi Admits Guilt in Killing of UnitedHealthcare CEO, Could Face Life Imprisonment","url":"https://stock-news.laohu8.com/highlight/detail?id=1151695113","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151695113?lang=en_us&edition=fundamental","pubTime":"2026-08-15 09:20","pubTimestamp":1786756847,"startTime":"0","endTime":"0","summary":"On August 14, local time, Luigi Mangione formally pleaded guilty to the murder of UnitedHealthcare CEO Brian Thompson. A federal judge has set Mangione's sentencing date for December 18.Mangione...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4585","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659124864","title":"Health Care Down on Growth Doubts - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2659124864","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659124864?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:19","pubTimestamp":1786742340,"startTime":"0","endTime":"0","summary":"Health-care companies fell amid doubts about the growth outlook for the sector.Pfizer shares were more or less flat after Albert Bourla, chief executive of the Big Pharma company, bought $1 million worth of shares, the latest major insider purchase on the open market, following the company's second-quarter earnings report.Luigi Mangione, who is accused of killing a UnitedHealthcare executive, pled guilty to federal stalking charges ahead of a high-profile state murder trial in New York set to begin next month.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","BK4581","BK4585","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121302","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121302","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121302?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:40","pubTimestamp":1786740009,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-us-physical-therapy-usph-and-adlai-nortye-ltd-sponsored-adr-anl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-us-physical-therapy-usph-and-adlai-nortye-ltd-sponsored-adr-anl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALN","LABU","BK4585","ANL","DINT","XLV","LU0012050646.USD","SAPH","BK4581","AADR","XBI","USPH","LU0128526141.USD","LU0106261612.USD","DIVL","BK4185","APIE","LU0029874061.USD","HCSG","ARMH","IE00BZ199S13.USD","CVY","BK4137","BK4588","BK4139","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659585126","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2659585126","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659585126?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:22","pubTimestamp":1786735351,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index decreasing 0.4% and the State Street Health Care Select Sector SPDR ETF  shedding 0.5%.The iShares Biotechnology ETF  lost 0.5%.In corporate news, Zentalis Pharmaceuticals  shares fell past 14% in Friday trading, a day after the company priced an offering of 23 million shares at $3.50 each, targeting about $80.5 million in gross proceeds.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","XLV","ZNTL","BK4588","LU0029874061.USD","BK4585","LABU","IBB","LU0128526141.USD","XBI","BK4137","HCSG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":10,"totalSize":391,"code":"91000000","status":"200"}]}}